170 related articles for article (PubMed ID: 33900873)
1. High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies.
Pearce J; Khabra K; Nanji H; Stone J; Powell K; Martin D; Zebian B; Hettige S; Reisz Z; Bodi I; Al-Sarraj S; Bridges LR; Clarke M; Jones C; Mandeville HC; Vaidya S; Marshall LV; Carceller F
Pediatr Hematol Oncol; 2021 Nov; 38(8):707-721. PubMed ID: 33900873
[TBL] [Abstract][Full Text] [Related]
2. High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience.
Chiang J; Bagchi A; Li X; Dhanda SK; Huang J; Pinto SN; Sioson E; Dalton J; Tatevossian RG; Jia S; Partap S; Fisher PG; Bowers DC; Hassall TEG; Lu C; Zaldivar-Peraza A; Wright KD; Broniscer A; Qaddoumi I; Upadhyaya SA; Vinitsky A; Sabin ND; Orr BA; Klimo P; Boop FA; Ashford JM; Conklin HM; Onar-Thomas A; Zhou X; Ellison DW; Gajjar A; Robinson GW
Neuro Oncol; 2024 Jan; 26(1):178-190. PubMed ID: 37503880
[TBL] [Abstract][Full Text] [Related]
3. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.
Carceller F; Fowkes LA; Khabra K; Moreno L; Saran F; Burford A; Mackay A; Jones DT; Hovestadt V; Marshall LV; Vaidya S; Mandeville H; Jerome N; Bridges LR; Laxton R; Al-Sarraj S; Pfister SM; Leach MO; Pearson AD; Jones C; Koh DM; Zacharoulis S
J Neurooncol; 2016 Aug; 129(1):109-21. PubMed ID: 27180091
[TBL] [Abstract][Full Text] [Related]
4. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
5. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.
Rizzo D; Ruggiero A; Martini M; Rizzo V; Maurizi P; Riccardi R
Biomed Res Int; 2015; 2015():215135. PubMed ID: 26448930
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
8. Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).
Benesch M; Wagner S; Berthold F; Wolff JE
J Neurooncol; 2005 Apr; 72(2):179-83. PubMed ID: 15925999
[TBL] [Abstract][Full Text] [Related]
9. [Pediatric Glioma].
Terashima K; Ogiwara H
No Shinkei Geka; 2021 May; 49(3):640-646. PubMed ID: 34092570
[TBL] [Abstract][Full Text] [Related]
10. Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.
Espinoza JC; Haley K; Patel N; Dhall G; Gardner S; Allen J; Torkildson J; Cornelius A; Rassekh R; Bedros A; Etzl M; Garvin J; Pradhan K; Corbett R; Sullivan M; McGowage G; Stein D; Jasty R; Sands SA; Ji L; Sposto R; Finlay JL
Pediatr Blood Cancer; 2016 Oct; 63(10):1806-13. PubMed ID: 27332770
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
Sturm D; Pfister SM; Jones DTW
J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.
Pollack IF; Jakacki RI; Butterfield LH; Hamilton RL; Panigrahy A; Potter DM; Connelly AK; Dibridge SA; Whiteside TL; Okada H
J Clin Oncol; 2014 Jul; 32(19):2050-8. PubMed ID: 24888813
[TBL] [Abstract][Full Text] [Related]
13. Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.
Koschmann C; Zamler D; MacKay A; Robinson D; Wu YM; Doherty R; Marini B; Tran D; Garton H; Muraszko K; Robertson P; Leonard M; Zhao L; Bixby D; Peterson L; Camelo-Piragua S; Jones C; Mody R; Lowenstein PR; Castro MG
Oncotarget; 2016 Oct; 7(40):65696-65706. PubMed ID: 27582545
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
16. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
17. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura PP; Quintela NV; García MM; Del Barco Berrón S; Sarrió RG; Gómez JG; Castaño AG; Martín LMN; Rubio OG; Losada EP
Clin Transl Oncol; 2023 Sep; 25(9):2634-2646. PubMed ID: 37540408
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
Juratli TA; Qin N; Cahill DP; Filbin MG
Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
[TBL] [Abstract][Full Text] [Related]
19. Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.
Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M
Br J Cancer; 2018 Sep; 119(6):693-696. PubMed ID: 30220707
[TBL] [Abstract][Full Text] [Related]
20. Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience.
Di Ruscio V; Carai A; Del Baldo G; Vinci M; Cacchione A; Miele E; Rossi S; Antonelli M; Barresi S; Caulo M; Colafati GS; Mastronuzzi A
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
